Net Income (Loss) Attributable to Parent of Caris Life Sciences, Inc. from 31 Dec 2023 to 31 Dec 2025

Taxonomy & unit: us-gaap: USD
Description: The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary: Caris Life Sciences, Inc. annual and quarterly Net Income (Loss) Attributable to Parent in USD history and change rate from 31 Dec 2023 to 31 Dec 2025.
Caris Life Sciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was $24,325,000.
Caris Life Sciences, Inc. annual Net Income (Loss) Attributable to Parent for 2025 was $68,088,000, a 76% increase from 2024.
Caris Life Sciences, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was $281,890,000, a 17% increase from 2023.
Source SEC data: View on sec.gov

Net Income (Loss) Attributable to Parent, Annual (USD)

Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

Net Income (Loss) Attributable to Parent, Quarterly (USD)

Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)

Caris Life Sciences, Inc. Annual Net Income (Loss) Attributable to Parent (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2025	$68,088,000	+$213,802,000	+76%	01 Jan 2025	31 Dec 2025	10-K	03 Mar 2026	2025	FY
2024	$281,890,000	+$59,525,000	+17%	01 Jan 2024	31 Dec 2024	10-K	03 Mar 2026	2025	FY
2023	$341,415,000			01 Jan 2023	31 Dec 2023	10-K	03 Mar 2026	2025	FY

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$24,325,000	+$92,054,000		01 Jul 2025	30 Sep 2025	10-Q	05 Nov 2025	2025	Q3
Q2 2025	$71,790,000	-$5,604,000	-8.5%	01 Apr 2025	30 Jun 2025	10-Q	12 Aug 2025	2025	Q2
Q3 2024	$67,729,000			01 Jul 2024	30 Sep 2024	10-Q	05 Nov 2025	2025	Q3
Q2 2024	$66,186,000			01 Apr 2024	30 Jun 2024	10-Q	12 Aug 2025	2025	Q2

* An asterisk sign (*) next to the value indicates that the value is likely invalid.